Authors: Costantino, L Rastelli, G Gamberini, MC Barlocco, D

Citation: L. Costantino et al., Pharmacological approaches to the treatment of diabetic complications, EXPERT OP T, 10(8), 2000, pp. 1245-1262

Authors: Ficarra, R Ficarra, P Di Bella, MR Raneri, D Tommasini, S Calabro, ML Gamberini, MC Rustichelli, C

Citation: R. Ficarra et al., Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation, J PHARM B, 23(1), 2000, pp. 33-40

Authors: Rustichelli, C Gamberini, G Ferioli, V Gamberini, MC Ficarra, R Tommasini, S

Citation: C. Rustichelli et al., Solid-state study of polymorphic drugs: carbamazepine, J PHARM B, 23(1), 2000, pp. 41-54

Authors: Rustichelli, C Gamberini, MC Ferioli, V Gamberini, G

Citation: C. Rustichelli et al., Properties of the racemic species of verapamil hydrochloride and gallopamil hydrochloride, INT J PHARM, 178(1), 1999, pp. 111-120

Authors: Costantino, L Rastelli, G Gamberini, MC Vinson, JA Bose, P Iannone, A Staffieri, M Antolini, L Del Corso, A Mura, U Albasini, A

Citation: L. Costantino et al., 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors, J MED CHEM, 42(11), 1999, pp. 1881-1893

Authors: Costantino, L Rastelli, G Gamberini, MC Giovannoni, MP Dal Piaz, V Vianello, P Barlocco, D

Citation: L. Costantino et al., Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors, J MED CHEM, 42(11), 1999, pp. 1894-1900